US Stock MarketDetailed Quotes

KYTX Kyverna Therapeutics

Watchlist
  • 3.030
  • -0.010-0.33%
Close Feb 14 16:00 ET
  • 3.010
  • -0.020-0.66%
Post 20:01 ET
130.81MMarket Cap-1.18P/E (TTM)

About Kyverna Therapeutics Company

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company. It develops treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Company Profile

SymbolKYTX
Company NameKyverna Therapeutics
Listing DateFeb 8, 2024
Issue Price22.00
CEOMr. Warner Weston Biddle
MarketNASDAQ
Employees96
Fiscal Year Ends12-31
Address5980 Horton Street,Suite 550
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-925-2492
Websitehttp://www.kyvernatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Warner Weston Biddle
  • Chief Executive Officer and Director
  • --
  • Karen Walker
  • Chief Technology Officer
  • 1.08M
  • Ryan Jones
  • Chief Financial Officer
  • --
  • Dominic Borie, M.D.
  • President, Research and Development
  • --
  • Ian T. Clark
  • Chairman of the Board
  • 306.74K
  • Christi Shaw
  • Director
  • --
  • Daniel K. Spiegelman
  • Independent Director
  • 245.05K
  • Dr. Steve Liapis, PhD
  • Independent Director
  • --
  • Mert Aktar
  • Independent Director
  • --
  • Dr. Fred E. Cohen, D.Phil.,F.A.C.P.,M.D.
  • Independent Director
  • 155.05K
  • Dr. Beth C. Seidenberg,M.D.
  • Independent Director
  • 155.05K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Avic Chengdu Aircraft
302132
0.00%
Wuhan Honghai Technology
920108
0.00%
Yalian Machinery
001395
0.00%
4
Beijing HyperStrong Technology
688411
0.00%
5
Fuling Technology
001356
0.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!